Loading…
Telomir Pharmaceuticals, Inc. is projected to rise to $1.37 by 2027, a +14% move from its current price of $1.21. TELO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.15 | $1.21 | $1.27 | -0.06% |
| Aug 6 | $1.13 | $1.21 | $1.30 | -0.11% |
| Aug 7 | $1.11 | $1.21 | $1.32 | -0.17% |
| Aug 8 | $1.09 | $1.21 | $1.34 | -0.22% |
| Aug 9 | $1.08 | $1.21 | $1.35 | -0.28% |
| Aug 10 | $1.07 | $1.21 | $1.36 | -0.34% |
| Aug 11 | $1.05 | $1.21 | $1.38 | -0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.05 | $1.21 | $1.38 | -0.39% |
| Week 2 | $0.9938 | $1.20 | $1.45 | -0.78% |
| Week 3 | $0.9487 | $1.20 | $1.51 | -1.17% |
| Week 4 | $0.9117 | $1.19 | $1.56 | -1.56% |
| Week 5 | $0.88 | $1.19 | $1.60 | -1.94% |
| Week 6 | $0.8519 | $1.18 | $1.64 | -2.33% |
| Week 7 | $0.8266 | $1.18 | $1.68 | -2.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Telomir Pharmaceuticals, Inc. is a preclinical-stage biotechnology company focused on developing small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria.
The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida. It is categorized in Healthcare.
A major floor 43.6% below — a decisive break under it would weaken the trend.
The nearest floor, 24.0% below — buyers have tended to step in here.
The nearest ceiling, 17.4% above — a clean break opens room to run.
A major ceiling 39.2% above — clearing it would confirm fresh momentum.
Key TELO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TELO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.22 | Sell | $1.21 | Buy |
| MA 10 | $1.14 | Buy | $1.19 | Buy |
| MA 20 | $1.18 | Buy | $1.19 | Buy |
| MA 50 | $1.24 | Sell | $1.23 | Sell |
| MA 100 | $1.28 | Sell | $1.27 | Sell |
| MA 200 | $1.31 | Sell | $1.45 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.78 | Neutral |
| Stoch RSI (14) | 89.89 | Sell |
| CCI (20) | 26.95 | Neutral |
| Williams %R (14) | -12.08 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 87.92 | Sell |
| TRIX (15) | -0.33 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 61.29 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 1.25 | Sell |
| ADX (14) | 10.06 | Neutral |
| ATR (14) | 0.05 | Info |
Telomir Pharmaceuticals, Inc. (TELO) currently trades at $1.25 and has a market capitalization of $85.97M, ranking 4008.
The 30-day range is $0.8887 to $1.76, with a SMA50 of $1.24 and a SMA200 of $1.32. The current technical picture shows support at $0.919 and resistance at $1.42.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.919 | $1.21 | $1.46 | 0% | Neutral | |
| $1.01 | $1.37 | $2.01 | +14% | Neutral | |
| $1.07 | $1.53 | $2.39 | +27% | Bullish | |
| $1.15 | $1.74 | $2.85 | +44% | Bullish | |
| $1.28 | $2.02 | $3.44 | +67% | Bullish | |
| $1.06 | $1.75 | $3.07 | +44% | Bullish | |
| $0.9714 | $1.66 | $3.01 | +37% | Bullish | |
| $1.01 | $1.80 | $3.35 | +49% | Bullish | |
| $1.13 | $2.08 | $3.96 | +72% | Bullish | |
| $1.45 | $2.77 | $5.39 | +129% | Bullish | |
| $1.36 | $3.01 | $6.44 | +149% | Bullish | |
| $2.11 | $4.68 | $10.76 | +287% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.919 | $1.21 | $1.39 | +0.00% |
| September 2026 | $0.949 | $1.15 | $1.45 | -4.91% |
| October 2026 | $0.936 | $1.15 | $1.48 | -0.07% |
| November 2026 | $0.8709 | $1.08 | $1.41 | -5.96% |
| December 2026 | $0.8812 | $1.10 | $1.46 | +2.18% |
Click any year to see its month-by-month TELO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, TELO could reach as high as $1.46, with a base case around $1.21 and support toward $0.919 — roughly 0% from $1.21. A consolidation phase looks the most probable path here.
Expect TELO to range from $1.01 to $2.01 through 2027. The $1.37 average target implies a +14% move from current prices. That is up +13% on the projected 2026 average. Price action looks broadly range-bound.
The TELO price prediction for 2028 points to an average of $1.53 (low $1.07, high $2.39) — a potential gain of +27% on today's $1.21. Buyers look set to stay in control over this stretch.
In 2029, TELO is projected to trade between $1.15 and $2.85, averaging $1.74 — a potential gain of +44% from today's $1.21. That is up +14% on the projected 2028 average. Momentum favours further upside here.
Telomir Pharmaceuticals, Inc.'s 2030 outlook centres on $2.02, within a $1.28 to $3.44 range. That is up +16% on the projected 2029 average. That marks a +67% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, TELO could reach as high as $3.07, with a base case around $1.75 and support toward $1.06 — roughly +44% from $1.21. Momentum favours further upside here.
Expect TELO to range from $0.9714 to $3.01 through 2032. The $1.66 average target implies a +37% move from current prices. That is -5% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The TELO price prediction for 2033 points to an average of $1.80 (low $1.01, high $3.35) — a potential gain of +49% on today's $1.21. Momentum favours further upside here.
In 2034, TELO is projected to trade between $1.13 and $3.96, averaging $2.08 — a potential gain of +72% from today's $1.21. That is up +15% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Telomir Pharmaceuticals, Inc.'s 2035 outlook centres on $2.77, within a $1.45 to $5.39 range. That is up +33% on the projected 2034 average. That marks a +129% change versus current levels. Momentum favours further upside here.
By 2040, TELO could reach as high as $6.44, with a base case around $3.01 and support toward $1.36 — roughly +149% from $1.21. Buyers look set to stay in control over this stretch.
Expect TELO to range from $2.11 to $10.76 through 2050. The $4.68 average target implies a +287% move from current prices. That is up +55% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TELO today (≈ 826.446281 TELO) could be worth
$3,867.76
+$2,867.76 (+287%) by 2050 · US Dollar
Based on the average projected TELO price of $4.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TELOwould be worth at today's price.
$1,000 invested in TELO on Jul 31, 2025 (≈ 534.759357 TELO) would be worth
$647.06
-$352.94 (-35.3%) today · 0.65× · US Dollar
Based on a TELO entry price of $1.87 vs. today's $1.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.15 | $1,052.17 | +5.2% |
| 1 month ago | $1.3 | $930.77 | -6.9% |
| 3 months ago | $1.4 | $864.29 | -13.6% |
| 6 months ago | $1.22 | $991.8 | -0.8% |
| 1 year ago | $1.87 | $647.06 | -35.3% |
| All time (2.5y) ago | $5 | $242 | -75.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TELO forecast.
Our base-case forecast reaches $2.40 around 2035.
Implied market cap at $2.40: $165.06M
Forecasts project a rising price path, with 2026 avg $1.25 and ROI 0, and sentiment neutral. The path continues with 2027 avg $1.42, 2028 avg $1.58, 2029 avg $1.82, and 2030 avg $2.11, achieving ROI 68.6% with a bullish tilt by 2030.
Tap a question to reveal the answer.
The 2030 forecast shows min $1.32, avg $2.11, max $3.61 with ROI 68.6% and sentiment BULLISH.
Forecasts show a path of growth with 2027 avg $1.42, 2028 avg $1.58, 2029 avg $1.82, 2030 avg $2.11, 2040 avg $3.11, and 2050 avg $4.88; ROI rises to 68.6% by 2030 and 290.5% by 2050, with bullish sentiment in later years, though these are estimates.
Yes. The 2035 forecast max is $5.70, with min $1.49 and avg $2.89; sentiment for that year is BULLISH.
The 30-day range is $0.8887 to $1.76, RSI14 is 50, SMA50 is $1.24, SMA200 is $1.32, with support at $0.919 and resistance at $1.42; sentiment is BULLISH.
Current price $1.25; Market cap $85.97M.
Telomir Pharmaceuticals, Inc. Community Discussion
0Share your Telomir Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.